PMC:7172841 / 21911-22321
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T125 | 18-21 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T126 | 33-42 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
T127 | 78-84 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T128 | 136-142 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T129 | 328-331 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T130 | 338-347 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T205 | 69-77 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T191 | 33-42 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
T192 | 78-84 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T193 | 136-142 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T194 | 194-204 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T195 | 338-347 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T121 | 22-24 | Chemical | denotes | DR | http://purl.obolibrary.org/obo/CHEBI_73445 |
T122 | 266-268 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T124 | 332-334 | Chemical | denotes | DR | http://purl.obolibrary.org/obo/CHEBI_73445 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T164 | 0-410 | Sentence | denotes | The expression of HLA-DR on CD14 monocytes was strongly inhibited by COVID-19 plasma from patients with immune dysregulation but not by plasma from patients with an intermediate immune state of activation (Figures 5C–5F); the addition of the specific blocker of the IL-6 pathway Tocilizumab partially restored the expression of HLA-DR on monocytes of all patients with immune dysregulation (Figures 5E and 5F). |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T80 | 104-124 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
T81 | 369-389 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T647 | 4-14 | GO:0010467 | denotes | expression |
T648 | 18-21 | PR:000029150 | denotes | HLA |
T649 | 28-32 | PR:000001889 | denotes | CD14 |
T650 | 33-42 | CL:0000576 | denotes | monocytes |
T651 | 69-77 | SP_7 | denotes | COVID-19 |
T652 | 78-84 | UBERON:0001969 | denotes | plasma |
T653 | 104-110 | UBERON:0002405 | denotes | immune |
T654 | 111-124 | GO:0065007 | denotes | dysregulation |
T655 | 136-142 | UBERON:0001969 | denotes | plasma |
T656 | 178-184 | UBERON:0002405 | denotes | immune |
T657 | 266-270 | PR:000001393 | denotes | IL-6 |
T658 | 279-290 | DG_35 | denotes | Tocilizumab |
T659 | 314-324 | GO:0010467 | denotes | expression |
T660 | 328-331 | PR:000029150 | denotes | HLA |
T661 | 338-347 | CL:0000576 | denotes | monocytes |
T662 | 369-375 | UBERON:0002405 | denotes | immune |
T663 | 376-389 | GO:0065007 | denotes | dysregulation |
T78000 | 39-45 | UBERON:0001969 | denotes | tes wa |
T62942 | 47-57 | GO:0065007 | denotes | strongly i |
T73958 | 90-94 | PR:000001393 | denotes | pati |
T4451 | 103-115 | DG_35 | denotes | immune dysr |
T60524 | 156-159 | PR:000029150 | denotes | wi |
T50596 | 166-170 | PR:000001889 | denotes | nter |
T33458 | 171-180 | CL:0000576 | denotes | ediate im |
T7540 | 212-222 | SP_7 | denotes | s 5C–5F); |
T18315 | 228-233 | UBERON:0002405 | denotes | ditio |
T79191 | 234-247 | GO:0065007 | denotes | of the speci |
T30207 | 287-293 | UBERON:0001969 | denotes | mab pa |
T4094 | 295-305 | GO:0065007 | denotes | ially rest |
T92474 | 338-342 | PR:000001393 | denotes | mono |
T42158 | 351-362 | DG_35 | denotes | all patient |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
947 | 28-32 | Gene | denotes | CD14 | Gene:929 |
948 | 266-270 | Gene | denotes | IL-6 | Gene:3569 |
957 | 90-98 | Species | denotes | patients | Tax:9606 |
958 | 148-156 | Species | denotes | patients | Tax:9606 |
959 | 355-363 | Species | denotes | patients | Tax:9606 |
961 | 279-290 | Chemical | denotes | Tocilizumab | MESH:C502936 |
967 | 69-77 | Disease | denotes | COVID-19 | MESH:C000657245 |